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Tuberculosis, a chronic infectious disease caused by My-
cobacterium tuberculosis, has reemerged as a leading
public health problem. Approximately one-third of the
world’s population is infected with M. tuberculosis, and
a recent World Health Organization report estimated
that, in 1998, there were 8 million new cases of clinical
tuberculosis and 1.9 million deaths from the disease.
Interestingly, not all individuals exposed to M. tuber-
culosis become infected. Moreover, progression toward
clinical tuberculosis is far from an inevitable conse-
quence of infection with M. tuberculosis, since only
∼10% of the vast number of infected individuals actually
develop clinical disease (Bloom and Small 1998). Both
M. tuberculosis infection and clinical tuberculosis result
from complex interactions between the infectious agent,
environmental factors, and the host.
The involvement of human genes in tuberculosis has
been suggested by numerous epidemiological observa-
tions. Several studies have shown that a person’s resis-
tance level to M. tuberculosis infection correlates with
the region of his or her ancestry and that the ancestors
of more-susceptible persons tend to come from areas
once free of tuberculosis (Stead 1992). Similarly, the in-
cidence of clinical tuberculosis has been found to be
particularly high during outbreaks in populations, such
as that of Native Americans, with no ancestral experi-
ence of the infection (Stead 1997). Twin studies have
also demonstrated the importance of host genes, by
showing higher concordance rates for clinical tubercu-
losis among MZ than among DZ pairs (Comstock
1978).
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Recent population-based studies have reported as-
sociations between some candidate genes and clinical
tuberculosis. Genes were selected on the basis of their
known or suspected role in innate or adaptive anti-
mycobacterial immunity. Association of tuberculosis
with some HLA class II alleles has been reported in
populations from Cambodia (Goldfeld et al. 1998)
and India (Ravikumar et al. 1999). Certain mannose-
binding–protein alleles have been shown to influence
tuberculosis in a population from India (Selvaraj et
al. 1999). Four polymorphic mutations of natural re-
sistance–associated macrophage protein 1 (NRAMP1)
were shown to predispose individuals to tuberculosis
in Gambia (Bellamy et al. 1998). In the same Gambian
population, an association was also reported with
polymorphisms in the vitamin D–receptor gene (Bel-
lamy et al. 1999). Finally, polymorphisms in the genes
encoding the cytokine interleukin (IL)-1beta and its
receptor antagonist IL-1Ra were found to be associ-
ated with tuberculosis in patients of Gujarati origin
who were living in England (Wilkinson et al. 1999).
The predisposing alleles reported in these studies have
only moderate effects, and their functional relevance
needs to be established before their role can be vali-
dated. Thus, the molecular basis of the genetic control
of clinical tuberculosis in large populations remains
largely elusive.
In contrast, there is clearly a causal relationship be-
tween certain rare Mendelian immunodeficiencies af-
fecting T cells or phagocytes and severe tuberculosis
(World Health Organization 1997). These rare patients
are vulnerable not only to M. tuberculosis but also to a
variety of other microorganisms. Recently, a genetic syn-
drome described as Mendelian susceptibility to myco-
bacterial infections (MIM 209950) has been extensively
investigated. Children and adults with this syndrome are
highly and specifically vulnerable to weakly virulent my-
cobacterial species, such as environmental nontubercu-
lous mycobacteria and live-attenuated bacille Calmette-
Gue´rin (BCG) vaccines. Different types of causal muta-
tions in four genes involved in IL-12–dependent inter-
feron (IFN)g–mediated immunity have been identified
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(Altare et al. 1998; Picard et al. 2000). The most-severe
genetic defects are invariably fatal in early childhood,
whereas other defects have a better prognosis and may
be revealed in adults. Remarkably, one child with a mild
defect who was not vaccinated with BCG had sympto-
matic tuberculosis (Jouanguy et al. 1997), which rep-
resents the first case of a specific Mendelian predispo-
sition to tuberculosis. However, these rare mutations
cannot account for the millions of tuberculosis cases re-
ported annually worldwide. There is, therefore, a gap
between causal susceptibility in rare individuals and un-
certain predisposition in general populations. In our
opinion, these two aspects of genetic predisposition to
tuberculosis do not conflict but, rather, are likely to rep-
resent the two ends of a continuous spectrum.
In this context, the article by Greenwood et al. (2000
[in this issue]) provides a unique opportunity to reconcile
these two extreme poles of tuberculosis genetics. That
article analyzes an extended pedigree rather than a single
patient or a large population. Predisposition to tuber-
culosis in that study is associated with a major gene effect
and is neither fully monogenic nor polygenic. More spe-
cifically, the authors analyzed a large aboriginal Cana-
dian pedigree after an epidemic of tuberculosis and
found, for the first time, convincing evidence of the ex-
istence of a major locus of susceptibility to clinical tu-
berculosis. This locus maps to chromosome 2q35 (two-
point LOD score 3.8; three-point LOD score 4.2), which
includes the NRAMP1 gene. The authors used a model-
based linkage method (classical LOD score) with both
a recessive and a dominant mode of inheritance assumed,
and, to model gene-environment interactions, they as-
signed individuals to risk (liability) classes on the basis
of age, BCG vaccination, tuberculin skin-test results, and
previous disease information. The specification of these
liability classes was crucial to obtaining evidence for
linkage, which stresses the importance of properly ac-
counting for the epidemiological context in this type of
analysis. Maximum LOD scores were obtained with a
dominant susceptibility allele having a major effect, since
carriers of at least one copy of this allele have a risk of
tuberculosis 10 times higher than that for wild-type
homozygotes.
Whether these results reflect the role of NRAMP1 it-
self or that of a closely linked gene remains to be es-
tablished. It is clear that NRAMP1 is an excellent can-
didate gene, since it is the human orthologue (Cellier et
al. 1994) of the murine Nramp1 gene (Vidal et al. 1993),
which regulates the early phase of mouse mycobacterial
infection. Functional studies have shown that Nramp1
has pleiotropic effects on macrophage function (Can-
onne-Hergaux et al. 1999). A single homozygous null
mutation in Nramp1 is associated with susceptibility to
several mycobacteria (Govoni et al. 1996; Vidal et al.
1996), including M. bovis BCG and M. lepraemurium,
the latter being the rodent-tropic equivalent ofM. leprae,
which causes leprosy in humans. The Nramp1 gene does
not appear to affect the susceptibility of mice to M. tu-
berculosis (North et al. 1999), but M. tuberculosis is not
a natural pathogen of rodents.
The major gene identified in the Canadian pedigree
studied by Greenwood et al. (2000) appears to control
the progression from infected status (individuals with
positive tuberculin skin test) to affected status (individ-
uals with tuberculosis) in a dominant manner. This mode
of inheritance is consistent with the results observed in
a Gambian case-control study (Bellamy et al. 1998) in
which the risks associated with one copy of one
NRAMP1 predisposing mutation were, however, much
smaller (odds ratio !2) than those observed for the major
susceptibility allele in the study by Greenwood et al.
(relative risks 10). The risks were larger (odds ratio ∼4)
for Gambian individuals heterozygous for two specific
mutations. Weak evidence for linkage between the
NRAMP1 region and tuberculosis was also reported in
multicase Brazilian families (Shaw et al. 1997). Further
supporting its role in mycobacterial diseases, NRAMP1
was found to be linked to susceptibility to leprosy per
se in Vietnam (Abel et al. 1998). In the same population,
NRAMP1 was shown to be linked to the in vivo Mitsuda
reaction, which assesses the delayed immune response
against intradermally injected lepromin (Alcais et al.
2000), indicating that NRAMP1 may also influence the
risk of M. leprae infection. Whether NRAMP1 can be
involved in the control of tuberculin skin-test reaction
and of M. tuberculosis infection is an important question
that deserves further study.
In any case, the results of Greenwood et al. (2000)
strongly support the view that, in certain genetic epi-
demiology contexts, predisposition to tuberculosis re-
sults mostly from major gene control. This kind of con-
trol for infectious diseases had already been suggested
by segregation studies for leprosy (Abel and Demenais
1988) and by schistosomiasis caused by the parasite
Schistosoma mansoni (Abel et al. 1991). In the latter
disease, linkage studies identified two distinct loci—one
controlling infection levels by S. mansoni (Marquet et
al. 1996) and the other determining progression from
infection to severe clinical disease (Dessein et al. 1999).
Overall, these results indicate that, as in some other com-
plex diseases (e.g., breast cancer and Alzheimer disease),
and at least in certain contexts, Mendelian-like suben-
tities can be involved in the genetic control of common
infectious diseases.
For tuberculosis, this may be the case for populations
that have not been extensively exposed to M. tubercu-
losis for a long time, such as the aboriginal Canadian
population studied by Greenwood et al. (2000). In such
populations and before antibiotics were available, the
incidence of tuberculosis during epidemics rapidly in-
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creased as the infection spread, slowing as the number
of uninfected susceptible subjects was reduced and de-
creasing to baseline as the pool of susceptible individuals
was depleted by death (Stead 1997). It is tempting to
speculate that highly susceptible individuals who died
early from the disease carried high-risk genotypes. Under
this hypothesis, the relatively rare susceptibility allele
identified by Greenwood et al. (2000) or any mutations
having similar effects (especially dominant ones) have
probably disappeared rapidly from populations with an
ancestral history of extensive exposure to M. tubercu-
losis. In such populations, however, other alleles, with
milder effects, may predispose to tuberculosis in a less-
pronounced manner.
The major-gene control reported by Greenwood et al.
(2000) supports the hypothesis of a continuous spectrum
in the genetic control of clinical tuberculosis, since it
bridges the gap between simple Mendelian susceptibility
and complex polygenic predisposition to clinical tuber-
culosis. This view of tuberculosis genetics has major im-
plications for future studies, which should benefit from
concepts and techniques developed in the fields corre-
sponding to the two poles of this spectrum. Progress
in the molecular genetic dissection of clinical tuberculo-
sis will likely come from complementary approaches
searching for rare Mendelian immune defects in partic-
ular patients with severe/uncommon clinical features,
major-gene effects in certain specific kindreds and pop-
ulations with no ancestral history of tuberculosis ex-
posure, and more-common polymorphisms with less-
pronounced effect in other populations with a longer
history of exposure to M. tuberculosis. An intriguing
question is whether a single gene could be involved in
the three levels of genetic control, with rare mutation(s)
being responsible for Mendelian susceptibility, relatively
rare variants having a major-gene effect, and more-com-
mon polymorphisms having a milder effect on the risk
of clinical tuberculosis.
This research has major biological implications for an
understanding of the genetic control of antimycobacter-
ial immunity. It is now urgent that we find new ways to
combat tuberculosis, one of the most fatal infectious
diseases worldwide (Murray and Salomon 1998; Dye et
al. 1999). The identification of host genes with their
functional alleles controlling the response to mycobac-
terial infection is fundamental to the definition of new
prevention (e.g., early detection and prolonged follow-
up of high-risk individuals) and treatment (e.g., aimed
at restoring partially deficient immune responses) strat-
egies for tuberculosis.
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